TW
GILD icon

TritonPoint Wealth’s Gilead Sciences GILD Stock Holding History

TritonPoint Wealth’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$334K Buy
2,397
+15
+0.6% +$2.1K 0.04% 211
2025
Q4 		$292K Sell
2,382
-4,679
-66% -$569K 0.03% 220
2025
Q3 		$784K Buy
7,061
+145
+2% +$16.5K 0.07% 177
2025
Q2 		$767K Buy
6,916
+243
+4% +$25.9K 0.07% 177
2025
Q1 		$748K Buy
6,673
+407
+6% +$42K 0.07% 178
2024
Q4 		$579K Buy
6,266
+381
+6% +$34.3K 0.05% 192
2024
Q3 		$492K Sell
5,885
-361
-6% -$27.5K 0.05% 210
2024
Q2 		$429K Sell
6,246
-1,631
-21% -$109K 0.04% 219
2024
Q1 		$681K Sell
7,877
-702
-8% -$54K 0.07% 170
2023
Q4 		$695K Buy
+8,579
New +$668K 0.07% 178

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

TritonPoint Wealth's GILD Position: Q1 2026 in Review

TritonPoint Wealth increased its Gilead Sciences (GILD) stake by 0.63% in Q1 2026, buying an estimated $2.1K and bringing the position to 2,397 shares worth $334K. The position accounts for 0.04% of the portfolio, ranked #211.

TritonPoint Wealth first reported a position in GILD in Q4 2023 and has held it in 10 quarters since. The position peaked at $784K in Q3 2025. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • TritonPoint Wealth held 2,397 shares of Gilead Sciences worth $334K as of Q1 2026.
  • TritonPoint Wealth bought 15 Gilead Sciences shares in Q1 2026, an estimated $2.1K.
  • Gilead Sciences made up 0.04% of TritonPoint Wealth's portfolio in Q1 2026, its #211 holding.
  • TritonPoint Wealth first reported a position in Gilead Sciences in Q4 2023 and has held it in 10 quarters since.
  • TritonPoint Wealth's Gilead Sciences position peaked at $784K in Q3 2025.
  • 2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on TritonPoint Wealth's 13F filing for Q1 2026, filed 21 Apr 2026.